Mutagenicity of paepalantine dimer and glycoside derivatives from Paepalanthus bromelioides

Toxicology in Vitro

Volumn 18, Issue 1, 2004, Pages 109-114

  Varanda, E A ^a   Devienne, K F ^a   Raddi, M S G ^a   Furuya, E M ^a   Vilegas, W ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Isocoumarins; Mutagenicity; Salmonella typhimurium

Indexed keywords

ALCOHOL; ALLOSE; ANTIINFECTIVE AGENT; CLASTOGEN; DICHLOROMETHANE; GLUCOSE; GLYCOSIDE; HERBACEOUS AGENT; ISOCOUMARIN DERIVATIVE; PAEPALANTHUS BROMELIOIDES EXTRACT; PAEPALANTINE 9 O BETA DEXTRO ALLOPYRANOSYL (1-6) GLUCOPYRANOSIDE; PAEPALANTINE 9 O BETA DEXTRO GLUCOPYRANOSIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; MEDICINAL PLANT; MUTAGENICITY; MUTATION; NONHUMAN; PAEPALANTHUS BROMELIOIDES; SALMONELLA TYPHIMURIUM;

PAEPALANTHUS; SALMONELLA TYPHIMURIUM;

EID: 0242657458     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2003.07.002     Document Type: Article

References (21)

1. Bae E.A., Han M.J., Choo M.K., Park S.Y., Kim D.H. Metabolism of 20(S)- and 20(R)-ginsenoside R-g3 by human intestinal bacteria and its relation to in vitro biological activities. Biological Pharmaceutical Bulletin. 25:2002;58-63.
2. Bernstein L., Kaldor J., MacCann J., Pike M.C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutation Research. 97:1982;267-281.
3. Coelho R.G., Vilegas W., Devienne K.F., Raddi M.S.G. A new cytotoxic naphthopyrone dimer from Paepalanthus bromelioides. Fitoterapia. 71:2000;497-500.
4. Devienne K.F., Raddi M.S.G., Varanda E.A., Vilegas W. In vitro cytotoxicity of some natural and semi-synthetic isocoumarins from Paepalanthus bromelioides. Zeitschrift-fur-Naturforschung. 57c:2002;85-88.
5. Hamburger M., Hostetmann K. Bioactivity in plants: the link between phytochemistry and medicine. Phytochemistry. 30(12):1991;3864-3884.
6. Hill R.A. Naturally occurring isocoumarins. Fortschritte der Chemie Organischer Naturstoffe. 49:1986;1-78.
7. ICH, 1995. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; Guidance on Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals. Recommended for Adoption at Step 4 of the ICH Process on 19 July.
8. Krishna G., Urda G., Thiess J. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective. Environmental and Molecular Mutagenesis. 32:1998;115-120.
9. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Research. 113:1983;173-215.
10. McGeorge L.J., Louis J.B., Atherholt T.B. and McGarrit G.J. (1983) Mutagenicity Analysis of Industrial Effluents:Background,results to date. Report of the New Jersey Department of Environmental Protection, Trenton.
11. Nath J., Krishna G. Safety screening of drugs in cancer therapy. Acta Haematologica. 99:1998;138-147.
12. Purves D., Harvey C., Tweats D., Lumley C.E. Genotoxicity testing: current practices and strategies used by the pharmaceutical industry. Mutagenesis. 10:1995;297-312.
13. Santos L.C., Andrade F.P., Vasconcelos E.C., Coelho R.G., Dokkedal A.L., Garcia A.L., Sano P.T., Vilegas W. Separation of flavonoids and naphtopyrones from four Brazilian Paepalanthus species by droplet countercurrent chromatography. Brazilian Journal Medical Plants. 2:1999;43-47.
14. Silva I.D., Rodrigues A.S., Gaspar J., Maia R., Laires A., Rueff J. Involvement of rat cytochrome 1 A 1 in the biotransformation of kaempferol to quercetin: relevance to the genotoxicity of kaempferol. Mutagenesis. 12:1997;383-390.
15. Simões C.M.O., Sckenkel E.P., Gosmann G., Mello J.C.P., Mentz L.A., Petrovick P.R. Farmacognosia: da planta ao medicamento. 1999;Universidade/ UFRGS/UFSC, Porto Alegre/Florianópolis.
16. Tavares D.C., Varanda E.A., Andrade F.D., Vilegas W., Takahashi C.S. Evaluation of the genotoxic potential of the isocoumarin paepalantine in in vivo and in vitro mammalian systems. Journal of Ethnopharmacology. 68:1999;115-120.
17. Varanda E.A., Raddi M.S.G., Dias F.L., Araujo M.C.P., Gibran S.C.A., Takahashi C.S., Vilegas W. Mutagenic and cytotoxicity activity of an isocoumarin (Paepalantine) isolated from Paepalanthus vellozioides. Teratogenesis Carcinogenesis and Mutagenesis. 17:1997;85-95.
18. Vargas V.M.F., Motta V.E.P., Henriques J.A.P. Mutagenic activity detected by Ames test river water under the influence of petrochemical industries. Mutation Research. 31:1993;31-45.
19. Vilegas W., Roque N.F., Salatino A., Giesbrecht A.M., Davino S. Isocoumarin from Paepalanthus bromelioides. Phytochemistry. 29:1990;2299-2301.
20. Vilegas W., Santos L.C., Alécio A.C., Pizza C., Piacente S., Pauw E.D., Sano P.T. Naphthopyranone glycosides from Paepalanthus bromelioides. Phytochemistry. 49:1998;207-210.
21. Weisburger J.H., Hara Y., Solan L., Luo F.Q., Pittman B., Zang E. Tea polyphenols as inhibitors of mutageniticity of major classes of carcinogens. Mutation Research. 371:1996;57-63.